Alexander R. Macalalad

Author

Analysis Group (United States)ORCID

Also Known As

A. Macalalad, A. R. Macalalad, A.R. Macalalad, Alexander Macalalad, Alexander R Macalalad, Alexander R. Macalalad

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Analysis Group (United States)Novartis (United States)Broad Institute Ragon Institute of MGH, MIT and Harvard Harvard University

About

Alexander R. Macalalad is an author at Analysis Group (United States) specializing in medicine, epidemiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	697
2	Public Health	2	2	339
3	Epidemiology	2	2	339
4	Immunology	2	2	659
5	Global Health	1	1	17

Alexander R. Macalalad

Publications

Citations

H-Index

Page 1

	Year	Citations
Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection Matthew R. Henn, Christian L. Boutwell, Patrick Charlebois, PLoS Pathogens ImmunologyCd4 T Cell ResponsesHiv-1 RevealsImmune RecognitionImmunotherapy	2012	337
Dynamics of Dengue Disease Severity Determined by the Interplay Between Viral Genetics and Serotype-Specific Immunity Molly OhAinle, Ángel Balmaseda, Alexander R. Macalalad, Science Translational Medicine Fitter VirusGenetic EpidemiologyImmunologyViral DynamicDengue Disease Severity	2011	322
Highly Sensitive and Specific Detection of Rare Variants in Mixed Viral Populations from Massively Parallel Sequence Data Alexander R. Macalalad, Michael C. Zody, Patrick Charlebois, PLoS Computational Biology	2012	139
Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib Stuart L. Goldberg, Lei Chen, Annie Guérin, Current Medical Research and Opinion	2013	53
The economic burden of brain metastasis among lung cancer patients in the United States A. Guérin, Medha Sasané, K. Dea, Journal of Medical Economics	2016	49
Treatment patterns and duration in post-menopausal women with HR+/HER2− metastatic breast cancer in the US: a retrospective chart review in community oncology practices (2004–2010) Alexander R. Macalalad, Yanni Hao, Peggy L. Lin, Current Medical Research and Opinion	2014	30
Treatment, overall survival, and costs in patients with<i>ALK</i>-positive non-small-cell lung cancer after crizotinib monotherapy A. Guérin, Medha Sasané, Heather A. Wakelee, Current Medical Research and Opinion	2015	24
Decision analysis to guide choice of interventions to reduce mother-to-child transmission of HIV Jeanne Bertolli, Dale J. Hu, Phillip Nieburg, AIDS	2003	22
ALK rearrangement testing and treatment patterns for patients with ALK-positive non-small cell lung cancer Annie Guérin, Medha Sasané, Jie Zhang, Cancer Epidemiology MedicineAlk RearrangementPathologyBronchial NeoplasmCancer Treatment	2015	21
Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection Annie Guérin, Medha Sasané, Christopher Hunt Keir, JAMA Oncology	2015	20

Page 1